Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.
The international community has been called upon to scale up cervical cancer interventions and progress against the only noncommunicable disease that can be eliminated.This call was made by the ...
Genmab has received approval from the Japan's Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat advanced or recurrent cervical cancer that progressed on or following ...
The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...